Company News

24 Mar 2020

Helperby Therapeutics initiates program aimed at a cure for the new coronavirus

Helperby Therapeutics aims to produce affordable, rapid and effective combination solutions to treat infectious disease. FIRST CRISIS: AMR The crisis of Antimicrobial resistance (AMR) has taken longer to unfold but...


Read full article here

19 Oct 2019

Are New Antibiotic Combinations The Solution To The AMR Crisis?

Combinations of old antimicrobials such as Helperby’s colistin and azidothymidine are a possible alternative to developing new chemical entities, because they cost one tenth of the price. A Global...


Read full article here

24 Sep 2019

The New England Journal of Medicine

The New England Journal of Medicine announces that Azidothymidine produces synergistic activity in combination with Colistin against antibiotic-resistant Enterobacteriaceae. Antimicrobial Agents Chemother. doi:10.1128/AAC.01630-18. The NEJM review entitled Colistin-Azidothymidine...


Read full article here

World News

23 Mar 2020

BBC reports Coronavirus continuing to develop globally

BBC reports Coronavirus continuing to develop globally...


Read full article here

25 Jan 2020

The Guardian Announces ‘Sepsis deaths around the world are twice as high as previously thought’.

Deaths from Sepsis are twice as high as previously thought...


Read full article here

21 Jul 2019

Urinary Tract Infections Affect Millions. The Cures Are Faltering.

As the infections become increasingly resistant to antibiotics, some standard treatments no longer work for an ailment that was once easily cured....


Read full article here

Key Papers

11 Jan 2020

Antibiotic Combination Therapy Against Resistant Bacteria Infections: Synergy, Rejuvenation & Resistance Reduction

Anti-Microbial Resistance (AMR) is a pandemic which threatens modern medicine. There is a lack of effective drug treatment due to the slow pace, high cost and low achievable sales prices...


Read full article here

16 Oct 2019

Are New Antibiotic Combinations The Solution To The AMR Crisis?

Combinations of old antimicrobials such as Helperby’s colistin and azidothymidine are a possible alternative to developing new chemical entities, because they cost one tenth of the price. A Global...


Read full article here

8 May 2019

Click here to view Helperby's recent press coverage


Read full article here